Cargando…
Comparing Gly(11)/dAla(11)-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the (111)In-SB3/(111)In-SB4 Radiotracer Pair
Background: The GRPR-antagonist (68)Ga-SB3 visualized prostate cancer lesions in animal models and in patients. Switching radiometal from (68)Ga to (111)In impaired tumor targeting in mice, but coinjection of the neprilysin (NEP)-inhibitor phosphoramidon (PA) stabilized (111)In-SB3 in circulation an...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471467/ https://www.ncbi.nlm.nih.gov/pubmed/30871262 http://dx.doi.org/10.3390/molecules24061015 |